{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:39:16Z","timestamp":1787589556485,"version":"build-2736575974"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jpsychires.2026.03.008","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T23:21:22Z","timestamp":1772925682000},"page":"243-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The dual role of GLP-1 receptor agonists in weight management and eating disorders: Potential benefits and risks"],"prefix":"10.1016","volume":"197","author":[{"given":"Aleksandra","family":"Leziak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Kochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8135-8482","authenticated-orcid":false,"given":"Piotr","family":"Koce\u0142ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jpsychires.2026.03.008_bib1","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3390\/nu11092086","article-title":"Food addiction: implications for the diagnosis and treatment of overeating","volume":"11","author":"Adams","year":"2019","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.03.008_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40211-020-00346-w","article-title":"A review of binge eating disorder and obesity. \u00dcbersicht zu Binge-eating und Adipositas","volume":"35","author":"Ag\u00fcera","year":"2021","journal-title":"Neuropsychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2026.03.008_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.536","article-title":"Association between use of oral hypoglycemic agents in Japanese patients with type 2 diabetes mellitus and risk of depression: a retrospective cohort study","volume":"7","author":"Akimoto","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"issue":"7","key":"10.1016\/j.jpsychires.2026.03.008_bib4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/npp.2016.246","article-title":"Endogenous glucagon-like peptide-1 receptor signaling in the nucleus tractus solitarius is required for food intake control","volume":"42","author":"Alhadeff","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/osp4.619","article-title":"A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder","volume":"9","author":"Allison","year":"2023","journal-title":"Obes. Sci. Pract."},{"issue":"16","key":"10.1016\/j.jpsychires.2026.03.008_bib6","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.297.16.1819","article-title":"The right brain hypothesis for obesity","volume":"297","author":"Alonso-Alonso","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib7","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.psyneuen.2015.11.021","article-title":"GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality","volume":"65","author":"Anderberg","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.03.008_bib9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2337\/diabetes.52.2.252","article-title":"Role of leptin in the regulation of glucagon-like peptide-1 secretion","volume":"52","author":"Anini","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.eatbeh.2021.101482","article-title":"Overweight and obesity are associated with increased eating disorder correlates and general psychopathology in university women with eating disorders","volume":"41","author":"Balantekin","year":"2021","journal-title":"Eat. Behav."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.03.008_bib11","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-23-0405","article-title":"The emerging role of glucagon-like peptide-1 in binge eating","volume":"262","author":"Balantekin","year":"2024","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.jpsychires.2026.03.008_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/eat.24109","article-title":"Use of glucagon-like peptide-1 receptor agonists in eating disorder populations","volume":"57","author":"Bartel","year":"2024","journal-title":"Int. J. Eat. Disord."},{"issue":"2","key":"10.1016\/j.jpsychires.2026.03.008_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s42255-021-00344-4","article-title":"Central and peripheral GLP-1 systems independently suppress eating","volume":"3","author":"Brierley","year":"2021","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.03.008_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1037\/0021-843X.115.1.62","article-title":"Weight suppression is a robust predictor of outcome in the cognitive-behavioral treatment of bulimia nervosa","volume":"115","author":"Butryn","year":"2006","journal-title":"J. Abnorm. Psychol."},{"issue":"5","key":"10.1016\/j.jpsychires.2026.03.008_bib15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-013-2841-0","article-title":"Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies","volume":"56","author":"Calanna","year":"2013","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.jpsychires.2026.03.008_bib16","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1172\/JCI74726","article-title":"Estrogens stimulate serotonin neurons to inhibit binge-like eating in mice","volume":"124","author":"Cao","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.jpsychires.2026.03.008_bib17","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/oby.22653","article-title":"Effects of liraglutide and behavioral weight loss on food cravings, eating behaviors, and eating disorder psychopathology","volume":"27","author":"Chao","year":"2019","journal-title":"Obesity"},{"issue":"8","key":"10.1016\/j.jpsychires.2026.03.008_bib18","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1007\/s11064-017-2250-8","article-title":"Liraglutide improves water maze learning and memory performance while reducing hyperphosphorylation of tau and neurofilaments in APP\/PS1\/Tau triple transgenic mice","volume":"42","author":"Chen","year":"2017","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.03.008_bib19","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2023.2474","article-title":"Postmarket safety profile of suicide\/self-injury for GLP-1 receptor agonist: a real-world pharmacovigilance analysis","volume":"66","author":"Chen","year":"2023","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib20","article-title":"Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA adverse event reporting system database","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"18","key":"10.1016\/j.jpsychires.2026.03.008_bib21","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1080\/14656566.2023.2271389","article-title":"Exploring the nexus of binge eating disorder (BED), new psychoactive substances (NPS), and misuse of pharmaceuticals: charting a path forward","volume":"24","author":"Chiappini","year":"2023","journal-title":"Expet Opin. Pharmacother."},{"issue":"12","key":"10.1016\/j.jpsychires.2026.03.008_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170671","article-title":"The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission","volume":"8","author":"Chuong","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib23","series-title":"Eating Disorders","article-title":"The connection between eating disorders and substance use disorders","author":"Claudat","year":"2023"},{"issue":"8","key":"10.1016\/j.jpsychires.2026.03.008_bib24","doi-asserted-by":"crossref","first-page":"e968","DOI":"10.4088\/JCP.15m10059","article-title":"Estimating the prevalence of binge eating disorder in a community sample from the United States: comparing DSM-IV-TR and DSM-5 criteria","volume":"77","author":"Cossrow","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2026.03.008_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.dsx.2020.03.009","article-title":"Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: a pilot study","volume":"14","author":"Da","year":"2020","journal-title":"Diabetes Metabol. Syndr."},{"key":"10.1016\/j.jpsychires.2026.03.008_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41110-020-00128-y","article-title":"The effects of COVID-19 quarantine on eating and sleeping behaviors","volume":"45","author":"da Silva","year":"2020","journal-title":"Nutrire"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuropharm.2019.03.035","article-title":"GLP-1\/dexamethasone inhibits food reward without inducing mood and memory deficits in mice","volume":"151","author":"D\u00e9carie-Spain","year":"2019","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.03.008_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/eat.22264","article-title":"Preliminary examination of glucagon-like peptide-1 levels in women with purging disorder and bulimia nervosa","volume":"48","author":"Dossat","year":"2015","journal-title":"Int. J. Eat. Disord."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.03.008_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ncpendmet0017","article-title":"Biologic actions and therapeutic potential of the proglucagon-derived peptides","volume":"1","author":"Drucker","year":"2005","journal-title":"Nat. Clin. Pract. Endocrinol. Metabol."},{"issue":"5","key":"10.1016\/j.jpsychires.2026.03.008_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0005-7967(02)00088-8","article-title":"Cognitive behaviour therapy for eating disorders: a \u201ctransdiagnostic\u201d theory and treatment","volume":"41","author":"Fairburn","year":"2003","journal-title":"Behav. Res. Ther."},{"issue":"8","key":"10.1016\/j.jpsychires.2026.03.008_bib31","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/eat.22717","article-title":"Defining \u201csignificant weight loss\u201d in atypical anorexia nervosa","volume":"50","author":"Forney","year":"2017","journal-title":"Int. J. Eat. Disord."},{"issue":"6","key":"10.1016\/j.jpsychires.2026.03.008_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib33","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jpsychires.2026.03.008_bib34","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.physbeh.2008.04.013","article-title":"Appetite-related gut peptides, ghrelin, PYY, and GLP-1 in obese women with and without binge eating disorder (BED)","volume":"94","author":"Geliebter","year":"2008","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.03.008_bib35","first-page":"184","article-title":"Disruption of glucagon-like peptide-1 signaling in Sim1 neurons reduces physiological and behavioral reactivity to acute and chronic stress","volume":"37","author":"Ghosal","year":"2017","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.jpsychires.2026.03.008_bib36","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1210\/en.2009-0915","article-title":"GLP-1(7-36)amide and exendin-4 stimulate the HPA axis in rodents and humans","volume":"151","author":"Gil-Lozano","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.713279","article-title":"Anxiety regarding COVID-19 is related to attentional control: the mediating role of anxiety sensitivity","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Psychiatr."},{"issue":"7","key":"10.1016\/j.jpsychires.2026.03.008_bib38","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/a-1844-1176","article-title":"The anti-obesity effect and safety of GLP-1 receptor agonist in overweight\/obese patients without diabetes: a systematic review and meta-analysis","volume":"54","author":"Guo","year":"2022","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.03.008_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imj.14691","article-title":"Current approach to eating disorders: a clinical update","volume":"50","author":"Hay","year":"2020","journal-title":"Intern. Med. J."},{"issue":"3","key":"10.1016\/j.jpsychires.2026.03.008_bib40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.physbeh.2012.02.017","article-title":"Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects","volume":"106","author":"Hayes","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.jpsychires.2026.03.008_bib41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnins.2015.00092","article-title":"GLP-1 based therapeutics: simultaneously combating T2DM and obesity","volume":"9","author":"Heppner","year":"2015","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.03.008_bib42","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/eat.24116","article-title":"Distinguishing probable atypical anorexia nervosa from weight loss alone in a national sample of U.S. military veterans: disentangling the roles of weight suppression and cognitive concerns","volume":"57","author":"Herb Neff","year":"2023","journal-title":"Int. J. Eat. Disord."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.03.008_bib43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/oby.22431","article-title":"Meal-related acyl and des-acyl ghrelin and other appetite-related hormones in people with obesity and binge eating","volume":"27","author":"Hernandez","year":"2019","journal-title":"Obesity"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib44","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/15622975.2023.2179663","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders","volume":"24","author":"Himmerich","year":"2023","journal-title":"World J. Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.03.008_bib45","doi-asserted-by":"crossref","DOI":"10.1080\/23312025.2016.1229086","article-title":"The physiological role of the brain GLP-1 system in stress","volume":"2","author":"Holt","year":"2016","journal-title":"Cogent Biol"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.03.008_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2337\/db18-0729","article-title":"Preproglucagon neurons in the nucleus of the solitary tract are the main source of brain GLP-1, mediate stress-induced hypophagia, and limit unusually large intakes of food","volume":"68","author":"Holt","year":"2019","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.jpsychires.2026.03.008_bib47","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/mp.2017.91","article-title":"A hippocampus to prefrontal cortex neural pathway inhibits food motivation through glucagon-like peptide-1 signaling","volume":"23","author":"Hsu","year":"2018","journal-title":"Mol. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2026.03.008_bib48","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1210\/en.2017-00812","article-title":"Characterization of the glucagon-like peptide-1 receptor in male mouse brain using a novel antibody and in situ hybridization","volume":"159","author":"Jensen","year":"2018","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.jpsychires.2026.03.008_bib49","doi-asserted-by":"crossref","first-page":"R885","DOI":"10.1152\/ajpregu.00520.2015","article-title":"GLP-1 and weight loss: unraveling the diverse neural circuitry","volume":"310","author":"Kanoski","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"9","key":"10.1016\/j.jpsychires.2026.03.008_bib50","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.biopsych.2012.11.020","article-title":"The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys","volume":"73","author":"Kessler","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.03.008_bib51","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1017\/S0007114521000921","article-title":"Systematic review of the effects of pandemic confinements on body weight and their determinants","volume":"127","author":"Khan","year":"2022","journal-title":"Br. J. Nutr."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.03.008_bib52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12966-019-0791-8","article-title":"Depression, emotional eating and long-term weight changes: a population-based prospective study","volume":"16","author":"Konttinen","year":"2019","journal-title":"Int. J. Behav. Nutr. Phys. Activ."},{"issue":"8","key":"10.1016\/j.jpsychires.2026.03.008_bib53","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"10.1016\/j.jpsychires.2026.03.008_bib54","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jpsychires.2026.03.008_bib55","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jamapsychiatry.2017.1220","article-title":"Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia spectrum disorder: a randomized clinical trial","volume":"74","author":"Larsen","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2026.03.008_bib56","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cpr.2009.01.007","article-title":"Weight change and appetite disturbance as symptoms of adolescent depression: toward an integrative biopsychosocial model","volume":"29","author":"Maxwell","year":"2009","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jpsychires.2026.03.008_bib57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mehy.2017.12.029","article-title":"Would glucagon-like peptide-1 receptor agonists have efficacy in BED and bulimia nervosa? A review of the current literature","volume":"111","author":"McElroy","year":"2018","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.03.008_bib58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/14740338.2023.2295397","article-title":"The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)","volume":"23","author":"McIntyre","year":"2024","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.jpsychires.2026.03.008_bib60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fendo.2017.00127","article-title":"Overlapping neural endophenotypes in addiction and obesity","volume":"8","author":"Michaud","year":"2017","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.jpsychires.2026.03.008_bib61","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pcd.2015.06.003","article-title":"Investigating incretin-based therapies as a novel treatment for depression in type 2 diabetes: findings from the South London Diabetes (SOUL-D) Study","volume":"10","author":"Moulton","year":"2016","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol. Metabol."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.03.008_bib63","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3945\/ajcn.111.014837","article-title":"Women with bulimia nervosa exhibit attenuated secretion of glucagon-like peptide 1, pancreatic polypeptide, and insulin in response to a meal","volume":"94","author":"Naess\u00e9n","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.jpsychires.2026.03.008_bib64","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s11606-018-4465-z","article-title":"Prevalence and correlates of disordered eating behaviors among young adults with overweight or obesity","volume":"33","author":"Nagata","year":"2018","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jpsychires.2026.03.008_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2022.113967","article-title":"Short-term effects of semaglutide on emotional eating and other abnormal eating patterns among subjects living with obesity","volume":"257","author":"Nicolau","year":"2022","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.jpsychires.2026.03.008_bib66","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1186\/s12889-023-15833-2","article-title":"Effect of the COVID-19 pandemic on obesity and its risk factors: a systematic review","volume":"23","author":"Nour","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib67","series-title":"The Heavy Burden of Obesity: the Economics of Prevention","year":"2019"},{"issue":"6","key":"10.1016\/j.jpsychires.2026.03.008_bib68","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/A:1008973106611","article-title":"The health-related quality of life in eating disorders","volume":"9","author":"Padierna","year":"2000","journal-title":"Qual. Life Res."},{"issue":"18","key":"10.1016\/j.jpsychires.2026.03.008_bib69","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/WNR.0000000000001545","article-title":"Glucagon-like peptide-1 receptors modulate the binge-like feeding induced by \u03bc-opioid receptor stimulation of the nucleus accumbens in the rat","volume":"31","author":"Pierce-Messick","year":"2020","journal-title":"Neuroreport"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib70","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s13679-021-00462-w","article-title":"The COVID-19, obesity, and food insecurity syndemic","volume":"11","author":"Pryor","year":"2022","journal-title":"Curr. Obes. Rep."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.03.008_bib71","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2023.2292461","article-title":"Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer's and Parkinson's diseases","volume":"12","author":"Rhea","year":"2024","journal-title":"Tissue Barriers"},{"issue":"5","key":"10.1016\/j.jpsychires.2026.03.008_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13709","article-title":"Highway to the danger zone? A cautionary account that GLP-1 receptor agonists may be too effective for unmonitored weight loss","volume":"25","author":"Richards","year":"2024","journal-title":"Obes. Rev."},{"key":"10.1016\/j.jpsychires.2026.03.008_bib73","article-title":"Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: a retrospective cohort study","volume":"7","author":"Richards","year":"2023","journal-title":"Obes. Pillars."},{"issue":"3","key":"10.1016\/j.jpsychires.2026.03.008_bib74","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.orcp.2015.03.005","article-title":"Improvement in binge eating in non-diabetic obese individuals after 3 months of treatment with liraglutide \u2013 a pilot study","volume":"9","author":"Robert","year":"2015","journal-title":"Obes. Res. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2026.03.008_bib75","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s40359-024-01613-z","article-title":"COVID-19-related distress, body image, and eating behaviors: a cross-sectional explanatory model","volume":"12","author":"Rodrigue","year":"2024","journal-title":"BMC Psychol."},{"issue":"14","key":"10.1016\/j.jpsychires.2026.03.008_bib76","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib77","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s40337-021-00456-y","article-title":"The association of obesity with eating disorders risk: online survey of a large cohort of Russian-speaking individuals seeking medical weight correction assistance","volume":"9","author":"Rukavishnikov","year":"2021","journal-title":"J. Eat. Disord."},{"issue":"6","key":"10.1016\/j.jpsychires.2026.03.008_bib78","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00431-015-2551-3","article-title":"Childhood obesity and its physical and psychological co-morbidities: a systematic review of Australian children and adolescents","volume":"174","author":"Sanders","year":"2015","journal-title":"Eur. J. Pediatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2026.03.008_bib80","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.biopsych.2008.09.028","article-title":"Binge-eating disorder: reward sensitivity and brain activation to images of food","volume":"65","author":"Schienle","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2026.03.008_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094433","article-title":"Association between obesity and selected morbidities: a study of BRICS countries","volume":"9","author":"Shukla","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jpsychires.2026.03.008_bib82","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/YCO.0000000000000818","article-title":"Worldwide prevalence of DSM-5 eating disorders among young people","volume":"35","author":"Sil\u00e9n","year":"2022","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.03.008_bib83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.biopsycho.2017.05.001","article-title":"Role of addiction and stress neurobiology on food intake and obesity","volume":"131","author":"Sinha","year":"2018","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.jpsychires.2026.03.008_bib84","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.physbeh.2016.04.013","article-title":"Central and peripheral glucagon-like peptide-1 receptor signaling differentially regulate addictive behaviors","volume":"161","author":"Sirohi","year":"2016","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.03.008_bib85","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1037\/0021-843X.110.1.124","article-title":"A prospective test of the dual-pathway model of bulimic pathology: mediating effects of dieting and negative affect","volume":"110","author":"Stice","year":"2001","journal-title":"J. Abnorm. Psychol."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.03.008_bib86","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ajcn\/nqaa146","article-title":"Weight suppression increases odds for future onset of anorexia nervosa, bulimia nervosa, and purging disorder, but not binge eating disorder","volume":"112","author":"Stice","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"issue":"12","key":"10.1016\/j.jpsychires.2026.03.008_bib87","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1007\/s00125-015-3754-x","article-title":"Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes","volume":"58","author":"ten Kulve","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1439179","article-title":"Connections between eating psychopathology, loneliness, and quality of life: insights from a multi-center study","volume":"15","author":"Todisco","year":"2024","journal-title":"Front. Psychiatr."},{"issue":"11","key":"10.1016\/j.jpsychires.2026.03.008_bib89","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamainternmed.2024.4369","article-title":"GLP-1 receptor agonist use and risk of suicide death","volume":"184","author":"Ueda","year":"2024","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.03.008_bib90","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-13-0414","article-title":"Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS","volume":"221","author":"van Bloemendaal","year":"2014","journal-title":"J. Endocrinol."},{"issue":"9","key":"10.1016\/j.jpsychires.2026.03.008_bib91","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/dom.12506","article-title":"Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans","volume":"17","author":"van Bloemendaal","year":"2015","journal-title":"Diabetes Obes. Metabol."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.03.008_bib92","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3892\/etm.2023.12054","article-title":"Therapeutic management of atypical antipsychotic-related metabolic dysfunctions using GLP-1 receptor agonists: a systematic review","volume":"26","author":"Vasiliu","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jpsychires.2026.03.008_bib94","series-title":"Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity","year":"1998"},{"key":"10.1016\/j.jpsychires.2026.03.008_bib95","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.physbeh.2016.12.034","article-title":"Systemic administration of anorexic gut peptide hormones impairs hedonic-driven sucrose consumption in mice","volume":"171","author":"Yamaguchi","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.jpsychires.2026.03.008_bib96","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(02)07952-7","article-title":"Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study","volume":"359","author":"Zander","year":"2002","journal-title":"Lancet"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626001561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626001561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:42:10Z","timestamp":1779428530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395626001561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":93,"alternative-id":["S0022395626001561"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.03.008","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dual role of GLP-1 receptor agonists in weight management and eating disorders: Potential benefits and risks","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}